comparemela.com

Byerik Swain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In patients with obesity, reducing weight, atherogenic lipids should be prioritized

In patients with obesity, reducing weight, atherogenic lipids should be prioritized
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Burst of antitachycardia pacing prior to ICD shock lowers risk for all-cause shock

A single burst of antitachycardia pacing before an implantable cardioverter defibrillator shock lowered risk for all-cause shock compared with a standard shock protocol, according to the results of the APPRAISE ATP trial.However, there was no difference between the groups in total shock burden, and the antitachycardia pacing (ATP)-plus-shock group had a greater burden of ventricular

In long QT syndrome, vigorous exercise appears OK regardless of age, sex, genotype

In long QT syndrome, vigorous exercise appears OK regardless of age, sex, genotype
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Pulsed field ablation system for AF demonstrates safety, efficacy in pivotal trial

Pulsed field ablation system for AF demonstrates safety, efficacy in pivotal trial
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Novel defibrillation lead beats safety, efficacy goals

A novel lead for use in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators exceeded the safety and efficacy thresholds in the LEADR trial, researchers reported at Heart Rhythm 2024. The defibrillation lead (OmniaSecure, Medtronic) was evaluated in the pivotal LEADR trial of 675 patients with a de novo indication for an ICD or CRT-D for primary or

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.